These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 32606893)

  • 1. Evaluation of Serum Level of FGF23 and 1,25(OH)
    Hassani S; Afkhamizadeh M; Teimouri A; Najaf Najafi M; Vazifeh Mostaan L; Mohebbi M
    Int J Gen Med; 2020; 13():289-295. PubMed ID: 32606893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased circulating levels of FGF23: an adaptive response in primary hyperparathyroidism?
    Witteveen JE; van Lierop AH; Papapoulos SE; Hamdy NA
    Eur J Endocrinol; 2012 Jan; 166(1):55-60. PubMed ID: 21984611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FGF23 and primary hyperparathyroidism: is there a link?
    Bilha SC; Gatu AA; Velicescu C; Bilha A; Florescu A; Branisteanu D
    Endokrynol Pol; 2020; 71(4):306-312. PubMed ID: 32598019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of vitamin D and FGF23 with serum ferritin in hypoparathyroid thalassemia: a case control study.
    Saki F; Salehifar A; Kassaee SR; Omrani GR
    BMC Nephrol; 2020 Nov; 21(1):482. PubMed ID: 33198660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanistic homeostasis of vitamin D metabolism in the kidney through reciprocal modulation of Cyp27b1 and Cyp24a1 expression.
    Meyer MB; Pike JW
    J Steroid Biochem Mol Biol; 2020 Feb; 196():105500. PubMed ID: 31629064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibroblast growth factor 23, parathyroid hormone, and 1alpha,25-dihydroxyvitamin D in surgically treated primary hyperparathyroidism.
    Tebben PJ; Singh RJ; Clarke BL; Kumar R
    Mayo Clin Proc; 2004 Dec; 79(12):1508-13. PubMed ID: 15595334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D and type II sodium-dependent phosphate cotransporters.
    Kido S; Kaneko I; Tatsumi S; Segawa H; Miyamoto K
    Contrib Nephrol; 2013; 180():86-97. PubMed ID: 23652552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of intestinal vitamin D receptor expression in experimental uraemia: effects of parathyroidectomy and administration of PTH.
    Szabó A; Schmutz A; Pesian S; Schmidt-Gayk H; Ritz E; Reichel H
    Nephrol Dial Transplant; 1998 Feb; 13(2):340-9. PubMed ID: 9509444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of plasma fibroblast growth factor 23 by calcium in primary hyperparathyroidism.
    Kobayashi K; Imanishi Y; Miyauchi A; Onoda N; Kawata T; Tahara H; Goto H; Miki T; Ishimura E; Sugimoto T; Ishikawa T; Inaba M; Nishizawa Y
    Eur J Endocrinol; 2006 Jan; 154(1):93-9. PubMed ID: 16381997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of prolactin and estrogen on the serum level of 1,25-dihydroxy vitamin D and FGF23 in female rats.
    Saki F; Sadeghian F; Kasaee SR; Koohpeyma F; Ranjbar Omrani GH
    Arch Gynecol Obstet; 2020 Jul; 302(1):265-271. PubMed ID: 32409924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left ventricular hypertrophy in primary hyperparathyroidism. Effects of successful parathyroidectomy.
    Piovesan A; Molineri N; Casasso F; Emmolo I; Ugliengo G; Cesario F; Borretta G
    Clin Endocrinol (Oxf); 1999 Mar; 50(3):321-8. PubMed ID: 10435057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FGF23, metabolic risk factors, and blood pressure in patients with primary hyperparathyroidism undergoing parathyroid adenomectomy.
    Nilsson IL; Norenstedt S; Granath F; Zedenius J; Pernow Y; Larsson TE
    Surgery; 2016 Jan; 159(1):211-7. PubMed ID: 26435425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The roles of calcium and 1,25-dihydroxyvitamin D3 in the regulation of vitamin D receptor expression by rat parathyroid glands.
    Brown AJ; Zhong M; Finch J; Ritter C; Slatopolsky E
    Endocrinology; 1995 Apr; 136(4):1419-25. PubMed ID: 7895652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parathyroid hormone suppression by 22-oxacalcitriol in the severe parathyroid hyperplasia.
    Funahashi H; Tanaka Y; Imai T; Wada M; Tsukamura K; Hayakawa Y; Matsuura N; Kikumori T; Oiwa M; Tominaga Y; Takagi H
    J Endocrinol Invest; 1998 Jan; 21(1):43-7. PubMed ID: 9633022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted genomic deletions identify diverse enhancer functions and generate a kidney-specific, endocrine-deficient
    Meyer MB; Benkusky NA; Kaufmann M; Lee SM; Redfield RR; Jones G; Pike JW
    J Biol Chem; 2019 Jun; 294(24):9518-9535. PubMed ID: 31053643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced parathyroid hormone-stimulated 1,25-dihydroxyvitamin d production in vitamin d sufficient postmenoposual women with low bone mass and idiopathic secondary hyperparathyroidism.
    Streeten EA; Rogstad AS; Flammer KM; Zarbalian K; Ryan K; Horwitz M; Holick MF; Shelton J
    Endocr Pract; 2013; 19(1):91-9. PubMed ID: 23186957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Cholecalciferol therapy on serum FGF
    Kamelian T; Saki F; Jeddi M; Dabbaghmanesh MH; Omrani GHR
    J Endocrinol Invest; 2018 Mar; 41(3):299-306. PubMed ID: 28795342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new analog of 1,25-(OH)2D3, 19-NOR-1,25-(OH)2D2, suppresses serum PTH and parathyroid gland growth in uremic rats without elevation of intestinal vitamin D receptor content.
    Takahashi F; Finch JL; Denda M; Dusso AS; Brown AJ; Slatopolsky E
    Am J Kidney Dis; 1997 Jul; 30(1):105-12. PubMed ID: 9214408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parathyroid Hormone Regulates Circulating Levels of Sclerostin and FGF23 in a Primary Hyperparathyroidism Model.
    Nagata Y; Imanishi Y; Tateishi T; Miyaoka D; Kurajoh M; Arnold A; Emoto M
    J Endocr Soc; 2022 Apr; 6(4):bvac027. PubMed ID: 35284773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.